title: Drug Points: Pseudophaeochromocytoma syndrome associated with clozapine.
authors.affiliation: Southampton General Hospital, Southampton SO16 6YG.
authors.forename: A J
authors.initials: AJ
authors.lastname: Krentz
authors.forename: S
authors.initials: S
authors.lastname: Mikhail
authors.forename: P
authors.initials: P
authors.lastname: Cantrell
authors.forename: G M
authors.initials: GM
authors.lastname: Hill
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000175:diagnosis; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D002395:Catecholamines / Q000652:urine; D003024:Clozapine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000139:chemically induced*; D008297:Male; D009765:Obesity / Q000139:chemically induced*; D010673:Pheochromocytoma / Q000175:diagnosis; D012559:Schizophrenia / Q000188:drug therapy / Q000652:urine; D013546:Sweating / Q000187:drug effects*; D013577:Syndrome; D013610:Tachycardia / Q000139:chemically induced*; D013997:Time Factors
chemical_list: D014150:Antipsychotic Agents; D002395:Catecholamines; D003024:Clozapine